LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 41 filers reported holding LOGICBIO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,290,000 | 0.43% |
| Orbimed Advisors | 8,466,783 | $38,778,000 | 0.43% |
| Sio Capital Management, LLC | 182,630 | $836,000 | 0.27% |
| Eversept Partners, LP | 349,919 | $1,602,629 | 0.11% |
| SAMLYN CAPITAL, LLC | 1,474,108 | $6,752,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 320,273 | $1,467,000 | 0.04% |
| PURA VIDA INVESTMENTS, LLC | 245,492 | $1,124,000 | 0.03% |
| SANDERS MORRIS HARRIS LLC | 35,000 | $160,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 176,500 | $808,000 | 0.02% |
| Ergoteles LLC | 65,827 | $301,000 | 0.01% |